Concepedia

Pharmacokinetics of docetaxel and ritonavir after oral administration of ModraDoc006/r in patients with prostate cancer versus patients with other advanced solid tumours

Marit A. C. Vermunt, Lisa T. van der Heijden, Jeroen J. M. A. Hendrikx, Alfred H. Schinkel, Vincent A. de Weger, Eric van der Putten, Baukelien van Triest, Andries M. Bergman, Jos H. Beijnen

Cancer Chemotherapy and Pharmacology · 2021 · 14 citations · 22 references

DOI

Concepts

References

22

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

Ian F. Tannock, Ronald de Wit, William R. Berry et al. · New England Journal of Medicine · 2004 · 5.7K citations

, , +12

Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)

Leora Horn, David R. Spigel, Everett E. Vokes et al. · Journal of Clinical Oncology · 2017 · 875 citations · Full text

, , +16

Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir

Irina F. Sevrioukova, T.L. Poulos · Proceedings of the National Academy of Sciences · 2010 · 286 citations · Full text

, , +17

Role of human cytochrome P450 3A4 and 3A5 in the metabolism of taxotere and its derivatives: enzyme specificity, interindividual distribution and metabolic contribution in human liver

Magang Shou, Michel Martinet, Kenneth R. Korzekwa et al. · Pharmacogenetics · 1998 · 190 citations

, , +17

Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.

Heleen A. Bardelmeijer, Mariët Ouwehand, Tessa Buckle et al. · PubMed · 2002 · 135 citations

, , +14